Trial Profile
Non-interventional Observational Study With Viramune Plus Antiretroviral Backbone Combination in HIV-infected Women and Male Patients. Gender Specific Evaluation of Data
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Nevirapine (Primary) ; Antiretrovirals
- Indications HIV infections
- Focus Adverse reactions
- Sponsors Boehringer Ingelheim Pharmaceuticals
- 10 Jan 2014 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 06 Mar 2013 Planned end date changed from 1 Mar 2015 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 14 Nov 2012 Planned End Date changed from 1 Dec 2013 to 1 Mar 2015 as reported by ClinicalTrials.gov.